v3.25.2
Unaudited Condensed Consolidated Statements of Changes in Equity - USD ($)
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Non- controlling interest
Total
Balance at Mar. 31, 2024 $ 105 $ 43,951,069 $ (41,384,268) $ (1,672,005) $ 3,159,103 $ 4,054,004
Balance (in Shares) at Mar. 31, 2024 1,051,804          
Net loss (673,420) (89,398) (762,818)
Foreign currency translation adjustment (62,320) 29,284 (33,036)
Balance at Jun. 30, 2024 $ 105 43,951,069 (42,057,688) (1,734,325) 3,098,989 3,258,150
Balance (in Shares) at Jun. 30, 2024 1,051,804          
Balance at Mar. 31, 2025 $ 105 43,951,069 (45,109,573) (1,697,164) 3,203,819 348,256
Balance (in Shares) at Mar. 31, 2025 1,051,804          
Net loss (164,397) (112,041) (276,438)
Exercise of November 2021 Private Placement Warrants $ 2 225,998 226,000
Exercise of November 2021 Private Placement Warrants (in Shares) 20,000          
Fair value of derivative liabilities upon exercise of warrants   3,196 3,196
Conversion of preferred stock into common stock $ 4 191,417 191,421
Conversion of preferred stock into common stock (in Shares) 36,471          
Additional shares of common stock round up adjustment due to retroactive effect of 1-for-10 reverse stock split  
Additional shares of common stock round up adjustment due to retroactive effect of 1-for-10 reverse stock split (in Shares) 37          
Foreign currency translation adjustment (43,522) (438) (43,960)
Balance at Jun. 30, 2025 $ 111 $ 44,371,680 $ (45,273,970) $ (1,740,686) $ 3,091,340 $ 448,475
Balance (in Shares) at Jun. 30, 2025 1,108,312